| 特征 | 总数n = 33 |
| 年龄(中位数，范围) | 41 (18~62) |
| 性别 |
|
| 男/女 | 16/17 |
| 疾病类型 |
|
| 急性髓系白血病/骨髓增生异常综合征 | 6 (18.18%) |
| 急性淋巴细胞白血病 | 3 (9.09%) |
| 慢性髓系白血病 | 1 (3.03%) |
| 霍奇金淋巴瘤 | 2 (6.06%) |
| 非霍奇金淋巴瘤 | 10 (30.30%) |
| 多发性骨髓瘤 | 7 (21.21%) |
| 再生障碍性贫血 | 4 (12.12%) |
| 移植前疾病状态 |
|
| 完全缓解 | 23 (69.70%) |
| 非完全缓解 | 10 (30.30%) |
| 移植类型 |
|
| 异基因 | 13 (39.39%) |
| 自体 | 20 (60.61%) |
| 造血干细胞来源 |
|
| 外周血 | 20 (60.61%) |
| 骨髓 + 外周血 | 7 (21.21%) |
| 骨髓 | 1 (3.03%) |
| 脐血 | 3 (9.09%) |
| 其它 | 2 (6.06%) |
| 预处理方案 |
|
| 自体 | 20 (60.61%) |
| BEAM | 12 (36.36%) |
| HD-MEL | 7 (21.21%) |
| BU/CY | 1 (3.03%) |
| 异基因 | 13 (39.39%) |
| BU\CY | 6 (18.18%) |
| ATG + CY | 2 (6.06%) |
| Flu + ATG + CY | 2 (6.06%) |
| 其他 | 3 (9.09%) |